Loading clinical trials...
Loading clinical trials...
The goal of the TAXUS™ Element™ Paclitaxel-Eluting Coronary Stent System European Post-Approval Surveillance Study is to evaluate real world clinical outcomes data for the TAXUS™ Element™ Coronary Ste...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Boston Scientific Corporation
Collaborators
NCT07165678 · Coronary Heart Disease
NCT07493603 · Coronary Heart Disease, Coronary Artery Disease, and more
NCT07451873 · Coronary Heart Disease
NCT06216847 · Coronary Heart Disease (CHD)
NCT07149688 · Atrial Fibrillation (AF), Hypertension, and more
Algemeen Ziekenhuis Sint-Jan
Bruges
CHU de Charleroi - ISPPC
Charleroi
H-Hartziekenhuis Roeselare-Menen vzw
Roeselare
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions